L. Proulx

Evaluation of VCH-759 monotherapy in hepatitis C infection

Curtis Cooper, Eric Lawitz, Peter Ghali et al. · Journal of Hepatology · 2009 · 70 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +12

Interactions between CRF, epinephrine, vasopressin and glucocorticoids in the control of acth secretion

Fernand Labrie, Vincent Giguère, L. Proulx et al. · Journal of Steroid Biochemistry · 1984 · 52 citations

Life Sciences, Endocrinology, Physiology +12

31 SAFETY AND ANTIVIRAL ACTIVITY OF THE HCV NON-NUCLEOSIDE POLYMERASE INHIBITOR VX-222 IN TREATMENT-NAIVE GENOTYPE 1 HCV-INFECTED PATIENTS

M. Rodríguez‐Torres, E. Läwitz, Barbara R. Conway et al. · Journal of Hepatology · 2010 · 38 citations · Full text

Medicine, Infectious Diseases, Pharmacotherapy +13

92 SAFETY, TOLERABILITY AND ANTIVIRAL ACTIVITY OF VCH-916, A NOVEL NON-NUCLEOSIDE HCV POLYMERASE INHIBITOR IN PATIENTS WITH CHRONIC HCV GENOTYPE-1 INFECTION

E. Läwitz, Curtis Cooper, M. Rodríguez‐Torres et al. · Journal of Hepatology · 2009 · 27 citations

Medicine, Infectious Diseases, Pharmacotherapy +9

Effect of Corticotropin-Releasing Factor on the Release and Synthesis of Prolactin

Gérard Morel, A Enjalbert, L. Proulx et al. · Neuroendocrinology · 2008 · 22 citations

Life Sciences, Endocrinology, Physiology +17